Literature DB >> 23628012

The meaning of different forms of structural myocardial injury, immune response and timing of infarct necrosis and cardiac repair.

Emanuela Turillazzi, Cristoforo Pomara, Stefania Bello, Margherita Neri, Irene Riezzo, Vittorio Fineschi1.   

Abstract

Although a decline in the all-cause and cardiac mortality rates following myocardial infarction (MI) during the past 3 decades has been reported, MI is a major cause of death and disability worldwide. From a pathological point of view MI consists in a particular myocardial cell death due to prolonged ischemia. After the onset of myocardial ischemia, cell death is not immediate, but takes a finite period of time to develop. Once complete myocytes' necrosis has occurred, a process leading to a healed infarction takes place. In fact, MI is a dynamic process that begins with the transition from reversible to irreversible ischemic injury and culminates in the replacement of dead myocardium by a fibrous scar. The pathobiological mechanisms underlying this process are very complex, involving an inflammatory response by several pathways, and pose a major challenge to ability to improve our knowledge. An improved understanding of the pathobiology of cardiac repair after MI and further studies of its underlying mechanisms provide avenues for the development of future strategies directed toward the identification of novel therapies. The chronologic dating of MI is of great importance both to clinical and forensic investigation, that is, the ability to create a theoretical timeline upon which either clinicians or forensic pathologists may increase their ability to estimate the time of MI. Aging of MI has very important practical implications in clinical practice since, based on the chronological dating of MI, attractive alternatives to solve therapeutic strategies in the various phases of MI are developing.

Entities:  

Mesh:

Year:  2015        PMID: 23628012     DOI: 10.2174/15701611113119990008

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  13 in total

1.  Early markers for myocardial ischemia and sudden cardiac death.

Authors:  Sara Sabatasso; Patrice Mangin; Tony Fracasso; Milena Moretti; Mylène Docquier; Valentin Djonov
Journal:  Int J Legal Med       Date:  2016-07-08       Impact factor: 2.686

2.  Immunohistochemical study on dystrophin expression in CAD-related sudden cardiac death: a marker of early myocardial ischaemia.

Authors:  Cristina Mondello; Luigi Cardia; Giovanni Bartoloni; Alessio Asmundo; Elvira Ventura Spagnolo
Journal:  Int J Legal Med       Date:  2018-05-07       Impact factor: 2.686

Review 3.  Immunohistochemical detection of early myocardial infarction: a systematic review.

Authors:  Cristina Mondello; Luigi Cardia; Elvira Ventura-Spagnolo
Journal:  Int J Legal Med       Date:  2016-11-25       Impact factor: 2.686

4.  Multiplex quantitative imaging of human myocardial infarction by mass spectrometry-immunohistochemistry.

Authors:  Aleksandra Aljakna; Estelle Lauer; Sébastien Lenglet; Silke Grabherr; Tony Fracasso; Marc Augsburger; Sara Sabatasso; Aurélien Thomas
Journal:  Int J Legal Med       Date:  2018-03-19       Impact factor: 2.686

Review 5.  Molecular tissue changes in early myocardial ischemia: from pathophysiology to the identification of new diagnostic markers.

Authors:  Aleksandra Aljakna; Tony Fracasso; Sara Sabatasso
Journal:  Int J Legal Med       Date:  2018-01-23       Impact factor: 2.686

Review 6.  Myocardial infarction from a tissue engineering and regenerative medicine point of view: A comprehensive review on models and treatments.

Authors:  Gozde Basara; Gokhan Bahcecioglu; S Gulberk Ozcebe; Bradley W Ellis; George Ronan; Pinar Zorlutuna
Journal:  Biophys Rev (Melville)       Date:  2022-08-30

7.  A theoretical timeline for myocardial infarction: immunohistochemical evaluation and western blot quantification for Interleukin-15 and Monocyte chemotactic protein-1 as very early markers.

Authors:  Emanuela Turillazzi; Marco Di Paolo; Margherita Neri; Irene Riezzo; Vittorio Fineschi
Journal:  J Transl Med       Date:  2014-07-02       Impact factor: 5.531

8.  miR-1, miR-499 and miR-208 are sensitive markers to diagnose sudden death due to early acute myocardial infarction.

Authors:  Enrica Pinchi; Paola Frati; Mariarosaria Aromatario; Luigi Cipolloni; Matteo Fabbri; Raffaele La Russa; Aniello Maiese; Margherita Neri; Alessandro Santurro; Matteo Scopetti; Rocco Valerio Viola; Emanuela Turillazzi; Vittorio Fineschi
Journal:  J Cell Mol Med       Date:  2019-06-26       Impact factor: 5.310

9.  Caffeoylquinic Acid Derivatives Extract of Erigeron multiradiatus Alleviated Acute Myocardial Ischemia Reperfusion Injury in Rats through Inhibiting NF-KappaB and JNK Activations.

Authors:  Zhifeng Zhang; Yuan Liu; Xuecong Ren; Hua Zhou; Kaishun Wang; Hao Zhang; Pei Luo
Journal:  Mediators Inflamm       Date:  2016-07-19       Impact factor: 4.711

Review 10.  Diagnosis of myocardial infarction at autopsy: AECVP reappraisal in the light of the current clinical classification.

Authors:  Katarzyna Michaud; Cristina Basso; Giulia d'Amati; Carla Giordano; Ivana Kholová; Stephen D Preston; Stefania Rizzo; Sara Sabatasso; Mary N Sheppard; Aryan Vink; Allard C van der Wal
Journal:  Virchows Arch       Date:  2019-09-14       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.